Tonix Pharmaceuticals stock halted ahead of FDA approval news
Ru Nathaniel, a director at Sweetgreen , Inc. (NYSE:SG), recently reported a sale of company stock valued at $50,527. According to the SEC filing, Nathaniel sold 2,123 shares of Class A Common Stock on March 17 at a price of $23.80 per share. This transaction was part of a "sell to cover" mandate under Sweetgreen’s equity incentive plans, aimed at satisfying tax withholding obligations. The sale price represents a significant premium to the stock’s 52-week low of $18.77, though still well below its high of $45.12. InvestingPro analysis indicates the stock has experienced notable volatility, with a 31% decline over the past six months.
Prior to this sale, Nathaniel also acquired 5,292 shares of Class A Common Stock on March 15 through a grant of fully vested Restricted Stock Units (RSUs). These RSUs were granted at no cost, representing a contingent right to receive one share of the company’s Class A common stock upon settlement.
Following these transactions, Nathaniel now holds 1,785,099 shares of Sweetgreen’s Class A Common Stock.
In other recent news, Sweetgreen Inc. reported its fourth-quarter 2024 earnings, which did not meet analyst expectations. The company posted an earnings per share (EPS) of -$0.25, missing the forecasted -$0.20, and reported revenue of $160.9 million, slightly below the anticipated $163.4 million. Despite the earnings miss, full-year sales grew by 15% to $676.8 million, marking the company’s first full year of positive adjusted EBITDA at $18.7 million. Analysts have responded with revised price targets: UBS lowered its target to $35 from $45 while maintaining a Buy rating, citing weather-related challenges and California wildfires impacting early 2025 performance. TD Cowen also adjusted its target to $33 from $45, noting a slowdown in restaurant traffic but maintaining a Buy rating due to Sweetgreen’s growth strategies. RBC Capital revised its target to $30 from $45, highlighting underperformance in same-store sales but expressing optimism about the company’s long-term strategies. Piper Sandler, meanwhile, maintained a Neutral rating with a $27 target, acknowledging Sweetgreen’s growth potential amidst current market volatility.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.